Crinetics Pharmaceuticals (CRNX) Interest Coverage Ratio (QoQ) (2017 - 2026)
Crinetics Pharmaceuticals (CRNX) Interest Coverage Ratio (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Crinetics Pharmaceuticals | 8.71 Bn | 8.71 Bn | 10.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -102.86% |
| Dec 31, 2025 | 5,825.42% |
| Sep 30, 2025 | 55.55% |
| Jun 30, 2025 | 97.15% |
| Mar 31, 2025 | -191.19% |
| Dec 31, 2024 | 24,913.54% |
| Sep 30, 2024 | 14.07% |
| Jun 30, 2024 | -33.15% |
| Mar 31, 2024 | -100.07% |
| Dec 31, 2023 | 76,951.85% |
| Sep 30, 2023 | 82.87% |
| Jun 30, 2023 | 29.29% |
| Mar 31, 2023 | 97.88% |
| Dec 31, 2022 | -10,025.74% |
| Sep 30, 2022 | 12.76% |
| Jun 30, 2022 | -130.07% |
| Mar 31, 2022 | 99.24% |
| Dec 31, 2021 | -15,445.27% |
| Sep 30, 2021 | 15.60% |
| Jun 30, 2021 | 37.07% |